CA-ANDERSEN-GLOBAL
Andersen Global indgår en samarbejdsaftale med full service-advokatfirmaet IBRAHIM & PARTNERS i De Forenede Arabiske Emirater, hvilket tilføjer dimension og dækning til organisationens eksisterende kapaciteter gennem sine medlems- og samarbejdsfirmaer i regionen.
Med kontorer i Abu Dhabi og Dubai har IBRAHIM & PARTNERS en af de bedste praksisser inden for fusioner og opkøb i landet. Firmaet blev grundlagt i 2018 og ledes af administrerende partner Ahmed Ibrahim, som tidligere ledede fusioner og opkøb hos et af de største advokatfirmaer i både De Forenede Arabiske Emirater og Mellemøsten. Derudover blev Ahmed rangeret som en Band 1 Capital Markets-advokat af Chambers and Partners i 2021 og blev tidligere rangeret som Tier 1 Capital Markets-advokat af Legal 500 i 2018.
Firmaet er også konsekvent blevet anerkendt af Chambers and Partners , The Legal 500 og IFLR1000 , og dets eksperters ekspertise omfatter retssager, arbejdsret, bankvirksomhed og finans, privat billighedsret og fonde, olie og gas, byggeri, energi og skat. Deres kapitalmarkedsafdeling er et af de mest aktive kapitalmarkedsafdelinger i De Forenede Arabiske Emirater og har ledet næsten alle landets børsnoteringer og tegningsretsudstedelser, herunder to udstedere fra De Forenede Arabiske Emirater, der er noteret på London Stock Exchange.
”Vores kunder er trygge ved vores kombination af juridisk viden, kommercialitet og sektorbevidsthed, hvilket afspejles i de omfattende, innovative løsninger, som vores eksperter leverer,” sagde Ahmed. ”Samarbejdet med Andersen Global giver os mulighed for at betjene vores kunder med behov på tværs af flere retskredse på en sømløs måde, og positionerer vores firma yderligere som en sammenligningsorganisation, der sætter standarden for uovertrufne, skræddersyede løsninger i De Forenede Arabiske Emirater.”
“IBRAHIM & PARTNERS konkurrerer med nogle af de største advokatfirmaer regionalt, og deres tjenestetilbud vil give os mulighed for fortsat at tilbyde kunder et bredt spektrum af uafhængige, integrerede løsninger,” tilføjede bestyrelsesformand for Andersen Global og administrerende direktør for Andersen, Mark Vorsatz. ”Deres regionale fodaftryk og grænseoverskridende ekspertise styrker vores eksisterende platform, idet denne region fortsætter med at udvikle sig som et vigtigt globalt marked.”
Andersen Global er en international sammenslutning af juridisk adskilte, uafhængige medlemsfirmaer bestående af skatte- og juraeksperter fra hele verden. Efter at være blevet etableret i 2013 af det amerikanske medlemsfirma Andersen Tax LLC har Andersen Global nu over 8.000 eksperter globalt og er repræsenteret på mere end 280 lokaliteter via sine medlems- og samarbejdsfirmaer.
Originalsprogsudgaven af denne bekendtgørelse er den officielle, autoriserede version. Oversættelserne er kun tænkt som en hjælp og bør sammenholdes med kildesprogsteksten, der som den eneste er juridisk bindende.
Se kildeudgaven på businesswire.com: https://www.businesswire.com/news/home/20210721005448/da/
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
New Clinical Study Publication Validates Respiratory Outcomes for the Onera Home-polysomnography System12.1.2026 14:30:00 CET | Press release
The results of this study provide further clinical evidence that patient-applied, patch-based PSG is a viable alternative to in-lab PSG, enabling broader access to gold-standard sleep testing. Onera Health, a leader in transforming sleep medicine, announces the recent publication of a multicenter validation study of its Onera Sleep Test System (STS) in the ERJ Open Research, a leading, fully open-access scientific journal published by the European Respiratory Society (ERS). This is the second publication from this study, and it demonstrates that the patch-based Onera STS home-polysomnography (hPSG) device accurately identifies respiratory events and distinguishes AHI severity when validated against simultaneous in-lab polysomnography and is a viable option for unattended home use. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112821647/en/ Patient sleeps with the patient-applied Onera home Polysomnography (Onera hPSG) so
Riskified Analysis Reveals 1 in 4 Refund Dollars Is Abusive; Introduces "Dynamic Returns," a New Policy Protect Feature, to Safeguard Revenue While Increasing Customer Satisfaction12.1.2026 14:00:00 CET | Press release
Riskified (NYSE: RSKD) a leader in ecommerce fraud and risk intelligence, today released a research analysis highlighting a growing customer experience dilemma: As merchants tighten controls to fight a surge in return and refund abuse, they are inadvertently creating a more restrictive and frustrating experience for their best customers. To help retailers mitigate this challenge, Riskified has introduced a new feature in its Policy Protect solution, Dynamic Returns, AI-powered return decisions that adapt in real-time based on customer eligibility. Riskified's 2024 analysis of over a million refund claims found that 1-2% of total order value measured in sales dollars was requested back as refunds, with nearly 1 in 4 dollars claimed being abusive. In response to rising abuse, many retailers are implementing restrictive tactics like flat return fees, shorter return windows, and delaying refunds, often taking 10+ days for warehouse inspection. These measures frustrate good customers, as 68
Esri’s Custom Chart Builder Adopted by the Shom (French Hydrographic and Oceanographic Office) for Nautical Chart Production12.1.2026 14:00:00 CET | Press release
Geospatial Solution for Safety-Critical Maritime Use Sets Global Benchmark for Chart Automation Esri, the global leader in location intelligence, announced today that the Shom (French Hydrographic and Oceanographic Office) has officially adopted Custom Chart Builder (CCB) for automated production of all paper nautical charts. Following extensive testing and configuration, Shom confirmed that CCB-generated charts meet the stringent safety standards required by the French Navy, marking a pivotal advancement in automating maritime cartography and reinforcing its role as a pioneer in maritime digital transformation. “This adoption demonstrates that high-quality, regulation-compliant paper charts can now be produced without manual intervention, dramatically reducing production time and cost,” said Rafael Ponce, Esri principal maritime consultant. “Shom’s endorsement validates Esri’s CCB as a trusted solution for hydrographic offices worldwide, supporting the transition to digital-first work
Cellares Expands Global Smart Factory Network With European Headquarters in the Netherlands12.1.2026 13:30:00 CET | Press release
Cellares’ new IDMO Smart Factory in Leiden, Netherlands, expands commercial-scale manufacturing capacity for European cell therapy patient populations through a standardized, automated, and highly scalable facility model Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced it has secured a site and signed a long-term lease for a new IDMO Smart Factory at Leiden Bio Science Park (LBSP) with Dura Vermeer Commercieel Vastgoed. The facility will serve as Cellares’ European headquarters and expand the company’s global manufacturing network with dedicated regional capacity. Cell therapy manufacturing is patient-specific and time-sensitive, making regional production capacity increasingly important as programs advance from clinical development toward commercial supply. The new Netherlands hub is designed to provide European drug developers with access to automated manufacturing infrastructure, while maintaining alignment to a common production stan
France Expands National AAC Access for Agenus' Botensilimab + Balstilimab for Ovarian Cancer and Soft-Tissue Sarcomas12.1.2026 13:30:00 CET | Press release
Updated national AAC protocol supports hospital-based, fully-reimbursed compassionate access across three solid tumor settings Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that France’s National Agency for Medicines and Health Products Safety (ANSM) has approved an updated national treatment protocol for botensilimab (BOT) plus balstilimab (BAL) under France’s Autorisation d’Accès Compassionnel (AAC) framework. The updated protocol expands France’s previously granted AAC authorization for BOT+BAL in patients with microsatellite-stable (MSS) metastatic colorectal cancer (mCRC) without active liver metastases to eligible patients with certain ovarian cancers and soft-tissue sarcomas—diseases with substantial unmet medical need after standard options have been exhausted. The revised protocol is designed to broaden the eligibility criteria, allowing more patients with advanced solid tumors to have early access to BOT+BAL under reimbursed compassionate
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum